Welcome from the ESH President

Dear Colleagues and Friends,

It is a great pleasure for us to invite you to attend the 23rd Scientific Meeting of the European Society of Hypertension (ESH) which will take place in Milan, Italy, from June 14 to 17, 2013.

The scientific program will continue the tradition of the many previous ESH meetings. That means that a major proportion of the program will be based on original research with oral and poster presentations which will be selected from the large number of abstracts submitted by the participants, based on the in depth assessment by reviewers of the abstracts.

The 2013 ESH meeting will also contain a broad range of clinical and experimental research papers presented in numerous State-of-the-Art lectures, Plenary Sessions, Debates, How-To and other Teachings Sessions, Breakfast Workshops, Integrated Sessions for ESH Working Groups and Satellite Symposia. The European Society of Hypertension has in various aspects developed educational activities in cooperation with other Scientific Societies. 

The ESH meeting attracts investigators, researchers, clinicians and other from all European countries but also many people with interest in hypertension from the Americas, Japan and Asia, the Middle-East and the Rest of the World. The scientific agenda contains the most updated research, controversies and consensus in the field of Clinical and Experimental hypertension and Vascular Protection. Over the years the ESH meeting has thus been steadily growing and several thousands people are expected, in Milan at ESH 2013, as well.

Hypertension and Vascular Protection creates an interest over a broad range of medical specialities from family medicine and general practise to the specialist fields of cardiology, nephrology and endocrinology and further to physiology and pharmacology. Hypertension is closely related to various cardiovascular, endocrine and renal diseases both as a cause and a consequence. Hypertension-induced organ damage results from the interaction of hemodynamic and non-hemodynamic factors, and multifactorial approach is necessary to halt the huge impact of high blood pressure in the burden of cardiovascular and renal diseases. New treatments and developments will be discussed in the meeting for outstanding specialits.

Rapid development of modern equipment and technical set-up for up-to-data ambulatory diagnostic work and non-invasive research on various aspects of the pathophysiology of hypertension, its hemodynamic profile and experimental research will be also updated.

You are all cordially invited to Milan and the European Society of Hypertension (ESH) meeting in June 2013!

Yours Sincerely,

Prof. Josep Redon
ESH President